SCIENTIFIC HUB

Araştırmanın izini sürün.

1.057 makale bulundu

“Parkinson progression” Aramayı temizle

Kaynak kaydı

Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative.

Brown EG, Chahine LM, Dobkin RD, Simuni T, Foroud T, Heathers LEA, Tropea TF, Stanley CE, McMahon BA, Brüggemann N, Klein C, Postuma RB, Johnson NS, Gochanour C, Caspell-Garcia C, Kurth R, Brumm MC, Coffey CS, Marek K, Tanner CM, Parkinson's Progression Markers Initiative.

Ann Neurol · 2026-05-14

DOI: 10.1002/ana.78246PMID: 42132059

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.
Açık erişim

Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.

Kang X, Lin Z, Calikusu FZ, Miller LA, Soriano S, Locascio JJ, Corvol JC, Maple-Grødem J, Fan Y, Mead K, Campbell MC, Elbaz A, Lesage S, Brice A, Hung AY, Schwarzschild MA, Hayes MT, Wills AM, Herrington TM, Liu G, Ravina B, Taba P, Kõks S, Simuni T, Forsgren L, Counsell C, Macleod AD, Beach TG, Alves G, Tysnes OB, Perlmutter JS, Heutink P, Kasten M, Mollenhauer B, Trenkwalder C, Klein C, Hepp DH, Backstrom D, Svenningsson P, Hu MT, Williams-Gray CH, Barker RA, International Genetics of Parkinson Disease Progression (IGPP) Consortium, Scherzer CR.

NPJ Parkinsons Dis · 2026-05-14

DOI: 10.1038/s41531-026-01367-yPMID: 42135313

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.
Kaynak kaydı

Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI.

Tanner CM, Stanley CE, Brown EG, Chahine LM, Weintraub D, Dobkin RD, Poewe W, Tolosa E, Marras C, Schade S, Chou KL, Pavese N, Coffey CS, Brumm MC, Kurth R, Noyce AJ, Gonzalez-Latapi P, Matthews-McGee A, Korell M, Meng C, Chen X, Racelo L, Ricci J, Fitzgerald C, Rigby NH, Battles JA, Carley JK, Singh Z, Kruchkow L, McMahon BA, Flagg E, Lemon LP, Talarico JM, Brodkin K, Destro C, Kuhl MM, Fabrizio K, Marek K, Tropea TF, Parkinson's Progression Markers Initiative.

Ann Neurol · 2026-05-10

DOI: 10.1002/ana.78245PMID: 42108656

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.
Kaynak kaydı

Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease.

Siderowf A, Heathers LEA, Fabrizio K, Kuhl MM, Kopil CM, Flagg E, McMahon BA, Coffey CS, Bright A, Totten M, Lemon LP, Bryan E, Prakash N, Pavese N, Bloem BR, Alcalay RN, Mirelman A, Stefanis L, Okubadejo N, Tolosa E, Tanner CM, Simuni T, Chowdhury S, Tropea TF, Marek K, Foroud T, Parkinson's Progression Markers Initiative.

Ann Neurol · 2026-05-10

DOI: 10.1002/ana.78239PMID: 42108682

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.
Kaynak kaydı

How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease.

Simuni T, Coffey CS, Kopil CM, Allen-Savietta C, Wendelberger B, Crawford A, Schneider RB, Siderowf A, Kieburtz K, Tanner CM, Tropea TF, Whalen H, Ramia L, Kamp C, Reyes C, Fabrizio K, Willson T, Merriam E, Kuhl MM, Chowdhury S, Marek K, Parkinson's Progression Markers Initiative.

Ann Neurol · 2026-05-07

DOI: 10.1002/ana.78250PMID: 42095573

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

Filtreler

Filtreler

Temizle
Yayın yılı
Araştırma alanı
Yazar
Dergi
Yayın türü
Kaynak ve dil
Açık erişimErişim durumu yeniden kullanım izni anlamına gelmez.